Conferences & Events

IASLC Lung Cancer Immunotherapy Meeting 2018 (#LCI18)

IASLC Lung Cancer Immunotherapy Meeting 2018
GOAL AND PURPOSE: 

Immunotherapy has become a very promising treatment modality for patients with lung cancer. Despite these encouraging results, further progress must be made, both in terms of treatment modalities and how to select patients for immunotherapy.

The IASLC Lung Cancer Immunotherapy Meeting 2018 has both educational and scientific objectives. The program includes invited lectures and panel discussions by world leaders in the field. The meeting is open for scientific abstract submissions and presentations.

CONFERENCE RESOURCES:

Meeting Registration  Abstract Submission - Deadline: 2/9/18  Conference Agenda

Abstract Submission Guidelines Hotel Registration 

TARGET AUDIENCE: 
  • Surgeons
  • Medical oncologists
  • Radiation oncologists
  • Pulmonologists
  • Radiologists
  • Pathologists
  • Epidemiologists
  • Basic research scientists
  • Nurses
  • Allied health professionals
  • Advocacy members 
2018 REGISTRATION FEES: 

Registration

Registration Rates
Full Symposium Registration - IASLC Member $250.00 USD
Full Symposium Registration - Non-Member $350.00 USD
Full Symposium Registration -  Fellow/Nurse $75.00 USD
Full Symposium Registration - Advocate/Survivor $0.00
LEARNING OBJECTIVES: 
  •  Review the most recent scientific advances within immunotherapy for lung cancer and to make a roadmap for future studies to improve therapeutic results.
  •  Discuss the methodology of how to best select patients for immunotherapy.
  •  Emphasize future perspectives, such as immunoprevention of lung cancer. 
DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONFERENCE VENUE:

The Melia Castilla Hotel
Calle del Poeta Joan Maragall, 43, 28020 Madrid, Spain
Official Website

ORGANIZING COMMITTEE:

Tony Mok, Roy Herbst, Luis Paz-Ares, David Carbone, Fred Hirsch, Giorgio Scagliotti, Federico Cappuzzo, Pia Hirsch, Murry Wynes